Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.5.1.3 (
dihydrofolate reductase
)
5,819
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Yersinia
enterocolitica organisms secrete Yop proteins via the type III pathway. Translational fusion of yop genes to ubiquitin or
dihydrofolate reductase
results in hybrid proteins that cannot be secreted. The folding of hybrids prevents their own transport, but it does not hinder the type III secretion of other Yops.
...
PMID:Yop fusions to tightly folded protein domains and their effects on Yersinia enterocolitica type III secretion. 1205 71
The Ysc type III secretion system allows
Yersinia
enterocolitica to translocate virulence proteins, called Yop effectors, into the cytosol of eukaryotic cells. Some of the Yop effectors possess an individual chaperone called a Syc protein. The first 15 amino acids of the YopE effector constitute a secretion signal that is sufficient to promote secretion of several reporter proteins. Residues 15-50 of YopE comprise the minimal binding domain for the SycE chaperone. In this study, we investigated the secretion by the Ysc system of several YopE-
DHFR
hybrid proteins with different folding properties, and evaluated the role of SycE, the cognate chaperone of YopE, in this context. We have analysed the secretion of hybrids containing 16 (YopE16), 52 (YopE52) and 80 (the complete region covered by the chaperone, YopE80) amino acids of YopE or full-length YopE (YopEFL) with wild-type
DHFR
and two mutants with altered folding properties. The hybrids containing
DHFR
delta77, the mutant whose folding properties are the most drastically affected, could be secreted in all the conditions tested, even in the absence of the chaperone SycE. In contrast, DHFRwt could only be secreted fused to the first 52 amino acids of YopE, and its secretion was strictly dependent on SycE. The hybrids YopE80-DHFRwt and YopEFL-DHFRwt were not secreted. YopEFL-DHFRwt completely jammed the channel in an SycE-dependent fashion. Our experiments indicate that, in order to be secreted, proteins must be unfolded or only partially folded, and that TSS chaperones could keep their substrates in a secretion-competent conformation, probably by preventing their folding. In addition, they show that the secretion apparatus can reject folded proteins if they are not deeply engaged into the injectisome.
...
PMID:SycE allows secretion of YopE-DHFR hybrids by the Yersinia enterocolitica type III Ysc system. 1242 21
Type III machines of pathogenic
Yersinia
spp. transport Yop proteins across the bacterial envelope into host cells. Translational fusions of yopE to the
dihydrofolate reductase
gene (dhfr) or the beta-galactosidase gene (lacZ) generate hybrid proteins that block type III injection of Yop proteins into host cells, consistent with the canonical view that impassable
DHFR
and LacZ hybrids jam secretion machines. Mutations in repressors of posttranscriptional gene regulation,
Yersinia
enterocolitica yscM1 and yscM2 as well as
Yersinia
pestis lcrQ, relieve the YopE-
DHFR
-imposed blockade and restore type III injection into host cells. Genetic suppression of the type III blockade does not, however, promote YopE-
DHFR
secretion. A model is proposed whereby rejection of YopE-
DHFR
from the secretion pathway inhibits type III gene expression.
...
PMID:Rejection of impassable substrates by Yersinia type III secretion machines. 1619 80
Yersinia
type III machines secrete protein substrates across the bacterial envelope. Secretion signals of some substrates have been identified; however, the mechanisms whereby these signals interact with type III machines are not known. Here we show that fusion of YopR, an early secretion substrate, to the N terminus of
dihydrofolate reductase
(
DHFR
) or other tightly folded proteins generates impassable hybrids that cannot travel the type III pathway. YopR hybrids capture YscN, the ATPase that provides energy for type III transport reactions, in the bacterial cytoplasm. Eleven N-terminal residues function as the YopR secretion signal, which is required for both binding to YscN and blocking the type III pathway. When expressed during type III machine assembly, YopR-
DHFR
blocks all secretion. Delayed expression of YopR-
DHFR
, when yersiniae have already engaged the type III pathway, blocks secretion of early (YscP) but not of late (effector Yops) substrates. These observations support a model whereby type III machines are programmed to secrete a sequence of proteins that can be disrupted when an impassable early substrate interacts with the YscN ATPase and blocks the transport of late substrates.
...
PMID:Secretion signal recognition by YscN, the Yersinia type III secretion ATPase. 1705 Jun 89
Considering the risk represented by plague today as a potential biological warfare agent, we propose cytosolic
Yersinia
pestis
dihydrofolate reductase
(YpDHFR) as a new target to the design of selective plague chemotherapy. This enzyme has a low homology with the human enzyme and its crystallographic structure has been recently deposited in the Protein Data Bank (PDB). Comparisons of the docking energies and molecular dynamic behaviors of five known
DHFR
inhibitors inside a 3D model of YpDHFR (adapted from the crystallographic structure) and human
DHFR
(HssDHFR), revealed new potential interactions and suggested insights into the design of more potent HssDHFR inhibitors as well as selective inhibitors for YpDHFR.
...
PMID:Molecular modeling studies of Yersinia pestis dihydrofolate reductase. 2187 54